Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Programme
      • Companies
      • Registration
      • Application for Emerging Companies
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Programme
      • Companies
      • Registration
      • Application for Emerging Companies
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Diagnostic Test Accuracy of Diabetic Retinopathy Screening by Physician Graders Using a Hand-held Non-Mydriatic Retinal Camera at a Tertiary Level Medical Clinic

Author: Mapa Mudiyanselage Prabhath Piyasena (United Kingdom)

Co-authors: JLY Yip, D MacLeod, M Kim, GVS Murthy

Purpose

Diabetic retinopathy (DR) is a common complication of diabetes mellitus (DM), leading to sight loss if not detected and treated in time. Different models of DR screening (DRS) have been implemented in many parts of the world. In resource poor low and middle-income countries (LMICs) development of a DRS model is complex, due to lack of resources and skilled human resource. Therefore task-shifting and using locally adaptable technology is useful to initiate DRS. The evidence on diagnostic test accuracy (DTA) of DRS utilising retinal photographic studies by non-ophthalmologist personnel in LMIC settings is scarce. This study aims to demonstrate the functional and technical feasibility of using a hand-held non-mydriatic digital camera in a LMIC non-ophthalmic setting. We assessed the DTA of DR detection by general physicians using this method compared to the local clinical reference standard of mydriatic indirect ophthalmoscopy and bio-microscopic examination by a retinologist. This study was a component of a doctoral research project and Ethics approval was obtained from both Ethics Review Committees of the London School of Hygiene & Tropical Medicine-United Kingdom and the National Eye Hospital-Sri Lanka.

Setting/Venue

Nine general physicians from a tertiary level institution in Sri Lanka underwent a competency-based training programme following written informed consent, delivered by two retinologists. The training included the following: capturing retinal fields using a hand-held non-mydriatic fundus camera (Zeiss-Visuscout100®-Germany), identification of signs of DR using images and DR grading according to an adopted classification system based on the United Kingdom - National Screening System. The screening intervention validation study was conducted in a public sector tertiary level out-patient medical clinic in Sri Lanka.

Methods

A sample size of n=506 participants was chosen, in order to estimate the sensitivity within a margin of error 10% (based on 95% confidence intervals [CI]), with an expected sensitivity of 70% and prevalence of moderate non-proliferative DR among people with DM (PwDM) of 20%. This included an additional 25% to take account of ungradable images (i.e., <50% of the retina visible). Interim analysis was undertaken to ascertain the level of ungradable images and the sample size was increased to 700 PwDM. We selected 700 people with diabetes (PwDM) > 18 years of age, not previously screened or treated for DR, presenting at the medical clinic. Two-field retinal imaging was used to capture fundus images before and after pupil dilatation, using a hand-held non-mydriatic digital retinal camera. The images were captured and graded by two trained, masked independent physician graders. The DTA (sensitivity, specificity, and predictive values) of different levels of DR was assessed comparing physician’s grading with a retinologist’s clinical examination by mydriatic bio-microscopy, to identify any level of DR and referrable level DR (moderate non-proliferative DR and levels above).

Results

Eligible PwDM identified from medical clinical records and response rate was 84.7% (700/826). Mean age of the participants was 60.8 years (SD ±10.08). Ungradable image proportion in non-mydriatic imaging was 43.4% and decreased to 12.8% following pupil dilatation. Sensitivity of detection of any level of DR using non-mydriatic imaging (ungradable accounted as screen positives) was 82.7% (95% CI 78.4-86.5%) in grader-1 and 78.3% (95% CI 73.7-82.5%) in grader-2 and specificity values dropped to 70.4% (95% CI 67.6-73.1%) in grader-1 and 76.2% (95% CI 73.6-78.7%) in grader-2 in non-mydriatic imaging. As a pragmatic approach for a resource poor non-ophthalmic setting, we reported the DTA of DRS using non-mydriatic imaging and dilatation of the pupils of only those who have ungradable images (two-step process). In this sub-analysis, the eye which was ungradable even following mydriasis were considered as screen positives. We derived a sensitivity of referable level of DR 81.1% (95% CI 72.9-87.9%) for grader-1 and 82.1% (95% CI 74.0-88.6%) for grader-2. The specificity values were 95.4% (95% CI 94.2-96.5%) for grader-1 and 97.1% (95% CI 96.1-97.9%) for grader-2 in this approach. We observed an improved level of PPV (59.7-70.2%) and NPV (98.4-98.5%) in this strategy.

Conlusions

In this study we demonstrated that the diagnostic test accuracy of the physician graders was closer to the standard practice of national level screening programs in other settings. We conclude that 2-field retinal imaging using a hand-held digital camera at a medical clinic, by physician graders, with dilatation of pupil of those who have ungradable images, provides a valid modality to identify referable level of diabetic retinopathy. This strategy is an accurate screening method of detection of a referable level in a health care facility-based people with diabetes who are at risk of developing sight threatening diabetic retinopathy.

Financial Disclosure

None to disclose

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

Secretariat Address
European Society of Retina Specialists
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

Email: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2026 Vienna
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • Social Media Toolkit
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Programme
      • Companies
      • Registration
      • Application for Emerging Companies
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • 2025 Press
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Ramin Tadayoni Award 2026
    • Mentorship Programme 2026
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • Observership Grant Programme 2026
    • RMCR Award Programme 2026
    • EBO-Euretina Exam 2026
    • YOURS
      • Ophthalmologica Lecturer 2026 Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login

IMPORTANT INFORMATION

Beware of fraudulent websites, emails and hotel booking offers

www.euretina.org is the only official website of the European Society of Retina Specialists.
 
Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.
 
This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.
 
If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].